Parkin mutations and susceptibility alleles in late-onset Parkinson's disease

Annals of Neurology

Volumn 53, Issue 5, 2003, Pages 624-629

  Oliveira, Sofia A ^a   Scott, William K ^a   Martin, Eden R ^a   Nance, Martha A ^b   Watts, Ray L ^c   Hubble, Jean P ^d   Koller, William C ^e   Pahwa, Rajesh ^f   Stern, Matthew B ^g   Hiner, Bradley C ^h   Ondo, William G ⁱ   Allen Jr , Fred H ^j   Scott, Burton L ^a   Goetz, Christopher G ^k   Small, Gary W ^l   Mastaglia, Frank ^m   Stajich, Jeffrey M ^a   Zhang, Fengyu ^a   Booze, Michael W ^a   Winn, Michelle P ^a   Middleton, Lefkos T ⁿ   Haines, Jonathan L ^o   Pericak Vance, Margaret A ^a   Vance, Jeffery M ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Struthers Parkinson Center   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h MARSHFIELD CLINIC   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j Carolina Neurological Clinic   (United States)

^k RUSH UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁿ GLAXOSMITHKLINE   (United Kingdom)

^o VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; CYSTEINE; PARKIN; TRYPTOPHAN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; EXON; FEMALE; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIGASES; MALE; MIDDLE AGED; PARKINSON DISEASE; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; UBIQUITIN-PROTEIN LIGASES;

EID: 0038754178     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10524     Document Type: Article

References (25)

1. Scott WK, Nance MA, Watts RL, et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 2001;286:2239-2244.
2. Zhang Y, Gao J, Chung KKK, et al. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA 2000;97:13354-13359.
3. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
4. Abbas N, Lucking CB, Ricard S, et al. A wide variety of mutations in the Parkin gene are responsible for autosomal recessive parkinsonism in Europe. Hum Mol Genet 1999;8:567-574.
5. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's Disease rating scale. In: Fahn S, Marsden CD, Calne DB, et al., eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information, 1987:153-164.
6. Martin ER, Scott WK, Nance MA, et al. Association of singlenucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA 2001;286:2245-2250.
7. Vance JM, Ben Othmane K. Methods of genotyping. In: Haines JL, Pericak-Vance MA, eds. Approaches to gene mapping in complex human diseases. New York: Wiley-Liss, 1998:213-228.
8. Hattori N, Kitada T, Matsumine H, et al. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 1998;44:935-941.
9. Wang M, Hattori N, Matsumine H, et al. Polymorphism in the parkin gene in sporadic Parkinson's disease. Ann Neurol 1999;45:655-658.
10. Eggerding FA, Iovannisci DM, Brinson E, et al. Fluorescencebased oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations. Hum Mutat 1995;5:153-165.
11. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores and marker-sharing statistics. Am J Hum Genet 1996;58:1323-1337.
12. Scott WK, Rogala AR, Rampersaud E, et al. Parkin mutations and idiopathic Parkinson disease (PD). Am J Hum Genet 2000;67:19 (Abstract).
13. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the Parkin gene. N Engl J Med 2000;342:1560-1567.
14. Hedrich K, Marder K, Harris J, et al. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 2002;58:1239-1246.
15. Periquet M, Lucking C, Vaughan J, et al. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet 2001;68:617-626.
16. Oliveri RL, Zappia M, Annesi G, et al. The parkin gene is not involved in late-onset Parkinson's disease. Neurology 2001;57:359-362.
17. Farrer LA, Bowirrat A, Friedland RP, et al. Identification of multiple loci for Alzheimer disease in an inbred Israeli-Arab community. Am J Hum Genet 2001;69(suppl):200 (Abstract).
18. Hoenicka J, Vidal L, Morales B, et al. Molecular findings in familial Parkinson disease in Spain. Arch Neurol 2002;59:966-970.
19. West A, Periquet M, Lincoln S, et al. Complex relationship between Parkin mutations and Parkinson disease. Am J Med Genet 2002;114:584-591.
20. Klein C, Pramstaller PP, Kis B, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 2000;48:65-71.
21. Kahle PJ, Leimer U, Haass C. Does failure of parkin-mediated ubiquitination cause juvenile parkinsonism? Trends Biochem Sci 2000;25:524-527.
22. Shimura H, Hattori N, Kubo S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000;25:302-305.
23. Hilker R, Klein C, Hedrich K, et al. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett 2002;323:50-54.
24. Shimura H, Hattori N, Kubo S, et al. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol 1999;45:668-672.
25. West AB, Maraganore D, Crook J, et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet 2002;11:2787-2792.